Closed SARS-CoV-2 isothermal amplification nucleic acid detection kit
A sars-cov-2, kit technology, applied in DNA/RNA fragments, recombinant DNA technology, microbial determination/inspection, etc., can solve the problem that it is difficult to achieve real-time detection of new coronavirus pneumonia on-site and without nucleic acid extraction. steps, unfavorable rapid detection and other problems, to avoid secondary pollution, low detection cost, and good specificity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2020-06-12
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to the technical field of viral nucleic acid detection methods, in particular to a SARS-CoV-2 RT-LAMP nucleic acid detection primer set and a closed SARS-CoV-2 isothermal amplification nucleic acid detection kit. Background technique
[0002] With the release of the "Diagnosis and Treatment Program for Pneumonia Infected by Novel Coronavirus (Trial Sixth Edition)", the importance of nucleic acid testing as an important standard for diagnosis has been generally recognized. However, nucleic acid detection involves extraction, amplification, detection, etc., and has high requirements for the laboratory environment and operators. A complete nucleic acid detection procedure for the new coronavirus often requires professional testers to operate with their hands off the platform for more than 3 hours in a row, involving large-scale Therefore, the popularization and on-site application of nucleic acid detection are limited, which leads to...
Examples
Embodiment 1
[0050] This embodiment provides a closed SARS-CoV-2 isothermal amplification nucleic acid detection kit, the kit includes reaction premix A, reaction premix B, HNB chromogen, detection tube, standard positive template, negative control. The reaction premix consists of reaction premix A and reaction premix B. Wherein, the reaction premix A includes Bst DNA large fragment polymerase, AMV reverse transcriptase; the reaction premix B includes 10X reaction buffer, primer set, dNTPs, magnesium sulfate, betaine, 6wt% formamide and DEPC water.
[0051] The primer set includes a pair of outer primers F3-1 and B3-1, a pair of inner primers FIP-1 and BIP-1, and a pair of loop primers LF-1 and LB-1.
[0052] The nucleotide sequences of F3-1, B3-1, FIP-1, BIP-1, LF-1, LB-1 are as follows:
[0053] F3-1 (SEQ ID NO.1): 5'CTAGGTTTCAAACTTTACTTGC3';
[0054] B3-1 (SEQ ID NO.2): 5'CCTTTTTCTACAGTGAAGGATT3';
[0055] FIP-1 (SEQ ID NO.3):
[0056] 5'CACATAATAAGCTGCAGCACCA-TACATAGAAGTTATTTGACTCC...
Embodiment 2
[0071] In combination with the requirements of the detection standards detected by the kit of the present invention, clinical verification has been carried out on the samples to be tested.
[0072] Comparison of LAMP test results with qPCR test
[0073]
[0074] LAMP positive detection rate for positive samples: 100%
[0075] LAMP positive detection rate for negative samples: 100%